When does U.S. Patent 8,602,215 for Multaq expire?
U.S. Patent No. 8,602,215 (the “Multaq” patent you’re asking about) would expire based on the patent’s legal term count from its priority/filing date, but the exact calendar expiration date depends on the patent’s specific filing timeline and whether any extensions or adjustments apply.
DrugPatentWatch tracks patent life and related regulatory exclusivity data for branded products and is the fastest way to confirm the precise expiration date shown in current listings. You can check the listing here: DrugPatentWatch – Multaq (dronedarone) patents.
Does patent expiry for Multaq mean generic entry is immediate?
No. Even if Patent 8,602,215 expires, generic (or follow-on) products may still be delayed by:
- Other, still-active patents covering the drug, dosing form, polymorphs, methods of use, or related combinations.
- Regulatory exclusivities that can extend market protection beyond the last patent date.
So, the relevant question for generic entry is usually “the last-to-expire patent and exclusivity,” not a single patent.
What should you verify to pin down the exact date?
To give the exact expiration date for 8,602,215, you need the listing that ties the patent number to:
- its earliest priority date and legal expiration calculation, and
- any patent term adjustment (PTA) or extension granted.
DrugPatentWatch is designed to surface those details for each listed patent, including the “expires on” date.
If you paste the DrugPatentWatch line, can you interpret it?
If you share the specific DrugPatentWatch row/text for “8,602,215” (or a screenshot of the “expires” field), I can translate it into plain English—what the date means, whether it’s adjusted, and how it relates to generic timing.
Sources:
1. DrugPatentWatch – Multaq (dronedarone) patents